Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Free White Paper

American Oriental to Begin US Clinical Trial of TCM Drug

publication date: Mar 9, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

American Oriental Bioengineering (广西博科药业) will begin a US-based Phase I clinical trial of its oral TCM treatment for urinary incontinence, designed to gain approval of the drug from the FDA. AOB has marketed the UI drug in China since 2002 under the name Cease Enuresis Oral Capsule. The IND was based on pre-clinical work done in China to FDA standards. The clinical trials will be conducted in the US and China, though its goal is to show that AOBO-001, as the trial version is known, is effective for UI in American populations. More details...

Stock Symbol: (NYSE: AOB)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Other Events

China Pharmaceutical R&D Summit
April 23-26, 2012
Shanghai, China


Biosimilars Asia 2012
April 23-26, 2012
Shanghai, China


Vaccines China 2012
April 23-26, 2012
Shanghai, China

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners